StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$5.95−0.15 (-2.46%)

Close on Nov 19, 2026Market cap $797.73MP/E –Yield –

Immatics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Immatics's shares outstanding was 137M at Jun 30, 2026. For fiscal 2025 it was 122M, up 14.6% from the year before. The highest annual figure on record is 122M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025122M+14.6%
FY2024Dec 31, 2024107M+32.6%
FY2023Dec 31, 202381M+17.0%
FY2022Dec 31, 202269M+9.4%
FY2021Dec 31, 202163M+31.1%
FY2020Dec 31, 202048M+45.0%
FY2019Dec 31, 201933M0.0%
FY2018Dec 31, 201833M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026137M+32.6%
Q2 FY2025Jun 30, 2025122M+14.8%
Q4 FY2024Dec 31, 2024115M+48.8%
Q3 FY2024Sep 30, 2024110M+69.9%
Q2 FY2024Jun 30, 2024103M+63.8%
Q1 FY2024Mar 31, 2024106M+220.1%
Q2 FY2023Jun 30, 202377M–
Q2 FY2022Jun 30, 202265M–
Q2 FY2021Jun 30, 202163M–
Q2 FY2020Jun 30, 202033M–

More Immatics figures

See a number that looks wrong?